Page 46 - Škrgat, Sabina, ed. 2023. Severe Asthma Forum - Monitoring and Treatable Traits in Severe Asthma. Koper: University of Primorska Press. Severe Asthma Forum, 2
P. 46
posal of new diagnostic and classifica- chiectasis in severe asthma. Allergy.
tion criteria. Clin Exp Allergy. 2013 2011 May;66(5):679-85.
severe asthma forum 2: severe asthma - monitoring and treatable traits in severe asthma Aug;43(8):850-73. 17. Woolnough KF, Richardson M, New-
7. Asano K, MD, Hebisawa A, Takashi by C, et al. The relationship between
Ishiguro T et al. New clinical diagnos- biomarkers of fungal allergy and lung
tic criteria for allergic bronchopulmo- damage in asthma. Clin Exp Allergy.
nary aspergillosis/mycosis and its val- 2017 Jan;47(1):48-56.
idation. J Allergy Clin Immunol. 2021 18. Mistry H, Ajsivinac Soberanis HM,
Apr;147:1261-68.e5. Kyyaly MA, et al. The Clinical Implica-
8. Denning DW, O’Driscoll BR, et al. The tions of Aspergillus Fumigatus Sensiti-
link between fungi and severe asthma: zation in Difficult-To-Treat Asthma Pa-
A summary of the evidence. Eur Respir tients. J Allergy Clin Immunol Pract.
J. 2006 Mar;27(3):615-26. 2021 Dec;9(12):4254-67.e10.
9. Horner WE, Helbling A, Salvaggio JE, 19. Ozyigit LP, Monteiro W, Rick E-M, et
et al. Fungal allergens. Clin Microbiol al. Fungal bronchitis is a distinct clin-
Rev. 1995 Apr;8(2):161-79. ical entity which is responsive to anti-
10. Del Giacco SR, Bakirtas A, Bel E, et al. fungal therapy. Chron Respir Dis. 2021
Allergy in Severe Asthma. Allergy. 2017 Jan-Dec;18:1479973120964448. doi:
Feb;72(2):207-20. 10.1177/1479973120964448.
11. Yike I. Fungal Proteases and Their 20. Eraso IC, Sangiovanni S, Morales
Pathophysiological Effects. Mycopatho- EI, et al. Use of monoclonal anti-
logia. 2011 May;171(5):299-323. bodies for allergic bronchopulmona-
12. Balenga NA, Klichinsky M, Xie Z, et ry aspergillosis in patients with asth-
al. A fungal protease allergen provokes ma and cystic fibrosis: literature re-
airway hyper-responsiveness in asthma. view. Ther Adv Respir Dis. 2020
Nat Commun. 2015 Apr 13:6:6763. doi: Jan-Dec;14:1753466620961648. doi:
10.1038/ncomms7763. 10.1177/1753466620961648.
13. Basu T, Seyedmousavi S, Sugui JA, et 21. Dhariwal J, Hearn AP, Kavanagh JE,
al. Aspergillus fumigatus alkaline pro- et al. Real-World Effectiveness of Anti-
tease 1 (Alp1/Asp f13) in the airways IL-5/5R Therapy in Severe Atopic Eo-
correlates with asthma severity. J Aller- sinophilic Asthma with Fungal Sensiti-
gy Clin Immunol. 2018 Jan;141(1):423- zation. J Allergy Clin Immunol Pract.
5.e7. 2021 Jun;9(6):2315-20.e1.
14. Bonser LR, Erle DJ. Airway mu- 22. Eldaabossi SAM, Awad A, Anshasi N.
cus and asthma: the role of MU- Mepolizumab and dupilumab as a re-
C5AC and MUC5B. J Clin Med. placement to systemic glucocorticoids
2017 Dec;6(12):112. doi: 10.3390/ for the treatment of Chronic Eosino-
jcm612011269. philic Pneumonia and Allergic Bron-
15. Burgel PR, Lazarus SC, Tam DC, et al. chopulmonary Aspergillosis - Case se-
Human eosinophils induce mucin pro- ries, Almoosa specialist hospital. Respir
duction in airway epithelial cells via Med Case Rep. 2021 Oct 1;34:101520.
epidermal growth factor receptor ac- doi: 10.1016/j.rmcr.2021.101520.
tivation. J Immunol. 2001 Nov 15;167 23. Woolnough K, Fairs A, Pashley CH,
(10):5948-54. et al. Allergic fungal airway disease:
16. Menzies D, Holmes L, McCumesky G, Pathophysiologic and diagnostic consid-
et al. Aspergillus sensitization is associ- erations. Curr Opin Pulm Med. 2015
ated with airflow limitation and bron- Jan;21(1):39-47.
tion criteria. Clin Exp Allergy. 2013 2011 May;66(5):679-85.
severe asthma forum 2: severe asthma - monitoring and treatable traits in severe asthma Aug;43(8):850-73. 17. Woolnough KF, Richardson M, New-
7. Asano K, MD, Hebisawa A, Takashi by C, et al. The relationship between
Ishiguro T et al. New clinical diagnos- biomarkers of fungal allergy and lung
tic criteria for allergic bronchopulmo- damage in asthma. Clin Exp Allergy.
nary aspergillosis/mycosis and its val- 2017 Jan;47(1):48-56.
idation. J Allergy Clin Immunol. 2021 18. Mistry H, Ajsivinac Soberanis HM,
Apr;147:1261-68.e5. Kyyaly MA, et al. The Clinical Implica-
8. Denning DW, O’Driscoll BR, et al. The tions of Aspergillus Fumigatus Sensiti-
link between fungi and severe asthma: zation in Difficult-To-Treat Asthma Pa-
A summary of the evidence. Eur Respir tients. J Allergy Clin Immunol Pract.
J. 2006 Mar;27(3):615-26. 2021 Dec;9(12):4254-67.e10.
9. Horner WE, Helbling A, Salvaggio JE, 19. Ozyigit LP, Monteiro W, Rick E-M, et
et al. Fungal allergens. Clin Microbiol al. Fungal bronchitis is a distinct clin-
Rev. 1995 Apr;8(2):161-79. ical entity which is responsive to anti-
10. Del Giacco SR, Bakirtas A, Bel E, et al. fungal therapy. Chron Respir Dis. 2021
Allergy in Severe Asthma. Allergy. 2017 Jan-Dec;18:1479973120964448. doi:
Feb;72(2):207-20. 10.1177/1479973120964448.
11. Yike I. Fungal Proteases and Their 20. Eraso IC, Sangiovanni S, Morales
Pathophysiological Effects. Mycopatho- EI, et al. Use of monoclonal anti-
logia. 2011 May;171(5):299-323. bodies for allergic bronchopulmona-
12. Balenga NA, Klichinsky M, Xie Z, et ry aspergillosis in patients with asth-
al. A fungal protease allergen provokes ma and cystic fibrosis: literature re-
airway hyper-responsiveness in asthma. view. Ther Adv Respir Dis. 2020
Nat Commun. 2015 Apr 13:6:6763. doi: Jan-Dec;14:1753466620961648. doi:
10.1038/ncomms7763. 10.1177/1753466620961648.
13. Basu T, Seyedmousavi S, Sugui JA, et 21. Dhariwal J, Hearn AP, Kavanagh JE,
al. Aspergillus fumigatus alkaline pro- et al. Real-World Effectiveness of Anti-
tease 1 (Alp1/Asp f13) in the airways IL-5/5R Therapy in Severe Atopic Eo-
correlates with asthma severity. J Aller- sinophilic Asthma with Fungal Sensiti-
gy Clin Immunol. 2018 Jan;141(1):423- zation. J Allergy Clin Immunol Pract.
5.e7. 2021 Jun;9(6):2315-20.e1.
14. Bonser LR, Erle DJ. Airway mu- 22. Eldaabossi SAM, Awad A, Anshasi N.
cus and asthma: the role of MU- Mepolizumab and dupilumab as a re-
C5AC and MUC5B. J Clin Med. placement to systemic glucocorticoids
2017 Dec;6(12):112. doi: 10.3390/ for the treatment of Chronic Eosino-
jcm612011269. philic Pneumonia and Allergic Bron-
15. Burgel PR, Lazarus SC, Tam DC, et al. chopulmonary Aspergillosis - Case se-
Human eosinophils induce mucin pro- ries, Almoosa specialist hospital. Respir
duction in airway epithelial cells via Med Case Rep. 2021 Oct 1;34:101520.
epidermal growth factor receptor ac- doi: 10.1016/j.rmcr.2021.101520.
tivation. J Immunol. 2001 Nov 15;167 23. Woolnough K, Fairs A, Pashley CH,
(10):5948-54. et al. Allergic fungal airway disease:
16. Menzies D, Holmes L, McCumesky G, Pathophysiologic and diagnostic consid-
et al. Aspergillus sensitization is associ- erations. Curr Opin Pulm Med. 2015
ated with airflow limitation and bron- Jan;21(1):39-47.
